BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 12933831)

  • 1. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.
    Skinner MA; Buddle BM; Wedlock DN; Keen D; de Lisle GW; Tascon RE; Ferraz JC; Lowrie DB; Cockle PJ; Vordermeier HM; Hewinson RG
    Infect Immun; 2003 Sep; 71(9):4901-7. PubMed ID: 12933831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge.
    Cai H; Yu DH; Hu XD; Li SX; Zhu YX
    DNA Cell Biol; 2006 Aug; 25(8):438-47. PubMed ID: 16907641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis.
    Wedlock DN; Skinner MA; Parlane NA; Vordermeier HM; Hewinson RG; de Lisle GW; Buddle BM
    Tuberculosis (Edinb); 2003; 83(6):339-49. PubMed ID: 14623164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.
    Wedlock DN; Denis M; Skinner MA; Koach J; de Lisle GW; Vordermeier HM; Hewinson RG; van Drunen Littel-van den Hurk S; Babiuk LA; Hecker R; Buddle BM
    Infect Immun; 2005 Jun; 73(6):3540-6. PubMed ID: 15908383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revaccination of cattle with bacille Calmette-Guérin two years after first vaccination when immunity has waned, boosted protection against challenge with Mycobacterium bovis.
    Parlane NA; Shu D; Subharat S; Wedlock DN; Rehm BH; de Lisle GW; Buddle BM
    PLoS One; 2014; 9(9):e106519. PubMed ID: 25180583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
    Hope JC; Thom ML; Villarreal-Ramos B; Vordermeier HM; Hewinson RG; Howard CJ
    Clin Exp Immunol; 2005 Jan; 139(1):48-56. PubMed ID: 15606613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.
    Skinner MA; Wedlock DN; de Lisle GW; Cooke MM; Tascon RE; Ferraz JC; Lowrie DB; Vordermeier HM; Hewinson RG; Buddle BM
    Infect Immun; 2005 Jul; 73(7):4441-4. PubMed ID: 15972546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteins.
    Wedlock DN; Keen DL; McCarthy AR; Andersen P; Buddle BM
    Vet Immunol Immunopathol; 2002 May; 86(1-2):79-88. PubMed ID: 11943331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis.
    Maue AC; Waters WR; Palmer MV; Nonnecke BJ; Minion FC; Brown WC; Norimine J; Foote MR; Scherer CF; Estes DM
    Vaccine; 2007 Jun; 25(24):4735-46. PubMed ID: 17499400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months.
    Thom ML; McAulay M; Vordermeier HM; Clifford D; Hewinson RG; Villarreal-Ramos B; Hope JC
    Clin Vaccine Immunol; 2012 Aug; 19(8):1254-60. PubMed ID: 22718125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.
    Vordermeier HM; Chambers MA; Cockle PJ; Whelan AO; Simmons J; Hewinson RG
    Infect Immun; 2002 Jun; 70(6):3026-32. PubMed ID: 12010994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines.
    Wedlock DN; Aldwell FE; Vordermeier HM; Hewinson RG; Buddle BM
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):220-7. PubMed ID: 22005585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of calves with Mycobacterium bovis Bacillus Calmette-Guerin reduces the frequency and severity of lesions of bovine tuberculosis under a natural transmission setting in Ethiopia.
    Ameni G; Tafess K; Zewde A; Eguale T; Tilahun M; Hailu T; Sirak A; Salguero FJ; Berg S; Aseffa A; Hewinson RG; Vordermeier HM
    Transbound Emerg Dis; 2018 Feb; 65(1):96-104. PubMed ID: 28168855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis.
    Blanco FC; Bianco MV; Garbaccio S; Meikle V; Gravisaco MJ; Montenegro V; Alfonseca E; Singh M; Barandiaran S; Canal A; Vagnoni L; Buddle BM; Bigi F; Cataldi A
    Tuberculosis (Edinb); 2013 May; 93(3):363-72. PubMed ID: 23518075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen.
    Biffar L; Blunt L; Atkins W; Anderson P; Holder T; Xing Z; Vordermeier M; McShane H; Villarreal-Ramos B
    Vaccine; 2020 Jan; 38(5):1241-1248. PubMed ID: 31759733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens.
    Buddle BM; Parlane NA; Keen DL; Aldwell FE; Pollock JM; Lightbody K; Andersen P
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):1-5. PubMed ID: 9874655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Cell Composition and Cytokine Expression Within Lymph Node Granulomas from BCG-Vaccinated and Non-vaccinated Cattle Experimentally Infected with Mycobacterium bovis.
    Salguero FJ; Gibson S; Garcia-Jimenez W; Gough J; Strickland TS; Vordermeier HM; Villarreal-Ramos B
    Transbound Emerg Dis; 2017 Dec; 64(6):1734-1749. PubMed ID: 27615603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis.
    Buddle BM; Wards BJ; Aldwell FE; Collins DM; de Lisle GW
    Vaccine; 2002 Jan; 20(7-8):1126-33. PubMed ID: 11803073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish.
    Hope JC; Thom ML; McAulay M; Mead E; Vordermeier HM; Clifford D; Hewinson RG; Villarreal-Ramos B
    Clin Vaccine Immunol; 2011 Mar; 18(3):373-9. PubMed ID: 21228141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.